Dr. Lingvay is a clinical investigator in the filed of diabetse, obesity, and associated metabolic complications. She leads an active clinical research program in the Division of Endocrinology at Univeristy of Texas Southwestern Medical Center in Dallas. Her research interests span from pathophysiology to finding new treatment options to improve the lives of patients with such conditions. Dr. Lingvay graduated from medical school among the top 5% of her class. She completed the Internal Medicine Residency at Texas Tech University in 2002, and Endocrinology, Diabetes and Metabolism Fellowship at University of Texas Southwestern Medical Center in 2005. Dr. Lingvay was selected to participate in the first class of the Clinical Research Scholars Program at UT Southwestern which she completed in 2008. In 2007 she received a National Institute of Health Career Development Award to study the role of pancreatic triglyceride accumulation in beta-cell failure and type 2 diabetes and to further develop her career as a clinical investigator. Dr. Lingvay also received the Master in Public Health degree from University of Texas School of Public Health in Houston in 2006. She has published her work in many renouned journals like JAMA New Engladn Journal of Medicine, Lancet, Circulation, and Diabetes Care. She has contributed to many textbooks in the field of diabetes and is on the editorial board of several journals. Dr. Lingvay has been invited to present lectures to her peers all over the world. She is an active member of American Diabetes Association, and has served on the scientific sessions organizing committee from 2016 to 2019.


Medical School
Carol Davila University of Medicine & Pharmacy (1998)
Texas Tech University Health Sciences Center (2002), Internal Medicine
UT Southwestern Medical Center (2005), Endocrinology & Metabolism
Graduate School
University of Texas Health Science Center at Houston (2006), Public Health
Graduate School
UT Southwestern Medical Center (2008), Clinical Research

Research Interest

  • Metabolic Syndrome
  • Nonalcoholic Fatty Liver Disease (NAFLD)
  • Nonalcoholic Steatohepatitis (NASH)
  • Obesity
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus


Featured Publications LegendFeatured Publications

Intensive Therapy in Newly Diagnosed Type 2 Diabetes: Results of a 6-Year Randomized Trial.
Harrison LB, Adams-Huet B, Li X, Raskin P, Lingvay I J. Investig. Med. 2014 Feb
Pancreatic Steatosis - Harbinger of Type 2 Diabetes in Obese Rodents
Lee Y, Lingvay I, Szczepaniak LS, Orci L, Unger RH Internal Journal of Obesity Fall 2010 34/2 396-400
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?
Lingvay I, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P Diabetes Care October 2009 32/10 1789-95
Noninvasive quantification of pancreatic fat in humans
Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS The Journal of Clinical Endocrinology & Metabolism Fall 2009 94/10 4070-6
Trends in thyroid cancer demographics and surgical therapy in the United States
Mitchell I, Livingston EH, Chang AY, Holt S, Snyder WH 3rd, Lingvay I, Nwariaku FE Surgery December 2007 142/6 823-8
Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes
Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS Journal of Investigative Medicine July 2007 55/5 230-6


Featured Books Legend Featured Books

Secondary Forms of Diabetes Mellitus. In American College of Physicians- Medicine

Lingvay I, Raskin P (2006). American College of Physicians

Non-insulin Pharmacological Therapies. In Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management

Lingvay I, Rhee C, Raskin P (2006).

Honors & Awards

  • Jean W. Wilson Award for Scientific Mentorship
  • Jean W. Wilson Award for Scientific Mentorship

Professional Associations/Affiliations

  • American Diabetes Association
  • American Federation for Medical Research
  • European Association for the Study of Diabetes
  • The Endocrine Society